Results 41 to 50 of about 42,598 (230)
Demonstration of nanofiltration‐based virus safety for AAV manufacturing using model viruses
Abstract Virus safety for biopharmaceutical products has been a well‐established concern for several decades. While various virus reduction steps have been identified and implemented for traditional plasma‐derived and monoclonal antibody products, there are various challenges to achieving the same virus safety in emerging gene therapy products.
Brian Buesing +2 more
wiley +1 more source
Infection rate of canine parvovirus in dogs presented at private veterinary clinics in Baghdad city
Background: Canine parvovirus is the primary etiology of hemorrhagic diarrhea and mortality in puppies worldwide. Aim: This study was designed to investigate canine parvovirus in dogs in Baghdad by rapid testing.
Khalid Ismael Oleiwi +3 more
doaj +1 more source
Development of methods for detection and eradication of mouse parvovirus from a laboratory mouse colony [PDF]
The mouse parvovirus designated MPV can infect laboratory mice and affect the humoral and cellular immune response of infected mice, reducing their value for biomedical and medical research.
Filipovska-Naumovska, Emilija
core
DNA concentration in harvest affects retrovirus clearance capabilities of protein A chromatography
Abstract Protein A chromatography is a key unit operation in biopharmaceutical purification, widely used to capture monoclonal antibodies (mAbs) from harvest cell culture fluid (HCCF). In addition to its primary function, protein A chromatography is also frequently tested for its ability to remove viruses. Although protein A specifically binds mAbs and
Lukas Döring +7 more
wiley +1 more source
Parvovirus-B19 and hematologic disorders
Parvovirus-B19 (PV-B19) küçük bir DNA virusu olup Parvoviridia ailesinin bir üyesidir. PV-B19 ile ilgili hastalıklar virus, konakçı cevabı ve immun sistem etkileşmesini temsil eden iyi birer örnektir. PV-B19 ilişkili hastalıklar, çocukluk çağında eritema
Sevgi Yetgin, Selin Aytaç Elmas
doaj +3 more sources
Background Passive immunity (mainly IgG) protects canine neonates from the highly pathogenic and contagious canine parvovirus, while it can also largely interfere with parvovirus early vaccinations.
Yalda Tamaddon +4 more
doaj +1 more source
Novel Parvovirus Related to Primate Bufaviruses in Dogs
A novel protoparvovirus species, related genetically to human bufaviruses, was identified in dogs with respiratory signs. The canine bufavirus was distantly related to the well-known canine protoparvovirus, canine parvovirus type 2, sharing low amino ...
Vito Martella +10 more
doaj +1 more source
INTRODUCTION[|]Parvovirus B19 belonging to the Erythrovirus genus is a single-stranded DNA virus in the family Parvoviridae. The present study aims to determine parvovirus B19 seropositivity in serum samples sent with pre-diagnosis of arthritis ...
Hilal Türkmen Albayrak +3 more
doaj +1 more source
Canine parvovirus is a truly new pathogen of dogs that emerged in the late 1970s. Initially seen as epidemic disease in all dogs, parvoviral enteritis is now primarily a disease of 1- to 6-month-old dogs. Maternal antibody interference with immunization accounts for the vast majority of vaccine "breaks." Molecular virologic methods have revealed ...
Pollock, Roy V.H., Coyne, Michael J.
openaire +2 more sources
“Shock séptico por parvovirus canino”
Spa: El parvovirus canino es una enfermedad de alta prevalencia en la práctica diaria de la medicina de pequeñas especies. Se manifiesta en dos formas principales: la forma cardíaca, que a menudo resulta en una muerte súbita pocos días después de la ...
Jove Mesa, Lucía Fernanda
core +1 more source

